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vitrsz study of ob/ob mouse and control mouse

erythrocytes and adipose tissue showed a difference in the
rate of glucose utilization as determined by the production
of 'H20.

In both ob/ob and control erythrocytes, glucose

utilization increased as glucose concentration of the medium
was increased, although the ob/ob rate was consistently
lower than the control.

The adipose tissues showed a

similar trend except for the ob/ob adipose tissue at 200
mg/d1 glucose concentration which exhibited a rate less than
the rate at 100 mg/d1.
The decreased glucose utilization by adipose tissue in
the absence of insulin or other hormonal stimuli suggested
that the difference may be due to a defect at the cellular
level rather than a hormonal effect.

Because erythrocyte

glucose utilization is not regulated by insulin, the results
of those incubations supported this idea.

The decreased

glucose utilization by the ob/ob erythrocytes gave further
evidence to the location of the defect.

3ince glucose

utilization in these cells is restricted to glycolysis and
to a lesser extent the pentose phosphate pathways the defect
would necessarily be limited to these pathways as well.

INTRODUCTION
The genetically obese mouse (ob obi was first described
in 1950 by Ingalls et al.

In America and :;candanavia the

mutation has been maintained on a background stock of
C57b1/6J mice (Bray and York 1979).

It has been demonstrated

that the defect is an autosomal recessive mutation on
chromosome six, 14 centimorgans from the
1978).

ig gene (Margules

fhe features exhibited by this mouse include obesity,

hyperglycemia, hyperinsulinemia, and insulin resistance
(hlouverakis and Ahite 1969; Genuth 1969; ;enuth et al.
1971; Findlay et al. 1973).

The syndrome in first expressed

by an observable weight gain by day 17-21. according to Bray
and York (1979).

The serum insulin level rises slightly at

this time and an accompanying hypoglycemia ensues, which is
eventually replaced by hyperglycemia.

Hyperplasia and

nypertrophy of adipose tissue continue until about six
months, when the condition stabilizes and the mouse has
reached an average weight of seventy-five grams. Deficient
non-shivering thermogenesis (e.g., fatty acid oxidation by
brown adipose tissue or skelatal muscle) has been reported
by some authors as the first detectable abnormality
(Trayhurn et al. 1977; Carnie and Smith 1980).

There is

much disagreement about the nature of the primary defect.
1

2
although there is agreement concerning ths major characteristics of the syndrome.
Altered function of pancreatic beta-cells has been
suggested as the cause of the hyperinsulinism and hence the
other characteristics (Genuth 1969; Ashcroft et al. 1970).
This idea was supported by Strautz (1968) who demonstrated
an ame1iorati3n of obesity and related symptoms by implantation of normal islets into the ob/ob mouse pancreas.

This

procedure resulted in reduction of serum insulin levels to
near normal.

Abraham et al. (1971) suggested that hyper-

secretion of insulin is secondary to an increased food
intake.

Genuth (1969) also presented evidence supporting

hyperphagis as the cause of hyperinsulinism.

Chlouverakis

and v,hite (1969) also reported improvement of the symptoms
of the syndrome when the ob/ob mice were maintainej on a
restricted diet.

Insulin resistances according to several

authors, is a result and not the cause of obesity and
hyperphagia (Chlouverakis and White 1969; Genuth et al.
1971; Beloit-Chain et al. 1973).

Raitada et al. (1980),

however, reported results showing decreased numbers of
insulin receptors in cultured ob/ob fibroblasts even after
several generations.
More recently, investigations to determine whether
altered glucose uptake and metabolism sre possible causes
or effects of the syndrome have been reported.

Cuendet

et al. (1976) has shown decreased glycolysis and 2-deoxyglucose uptake in the soleus muscle of the ob/ob mouse nnd

3
has suggested that a defect may be present in the transport
of glucose across the cell membrane or in phosphorylation.
A defect in glucose transport across cell membranes may
also be found in other tissues of thc ob/ob mouse.

Because

of the obvious importance of pancreatic islet cells in tne
.ation of the islets could
development of the syndrome, investi:
be expected to yield results that would help determine the
role of islet cell defects in causing the syndrome.

If, as

has been suggested, insulin release is controlled by glucose
processing up to the triose phosphate step (Coll-Garcia and
Gill 1969), then defective glucose transport or phosphorylation in pancreatic islets may play a role in aberrant insulin
production or secretion.

The idea of defective islet glucose

utilization and excess insulin secretion are not necessarily
contradictory.

According to Lavine et al. (1977). the blood

glucose level in the ob/ob mouse is above the insulin
stimulus threshold.

This could account for the high insulin

levels despite an islet cell abnormality.

That is, even if

the ob/ob islets show defective insulin secretion, the blood
glucose level is high enough to provide a continuous
stimulus for insulin secretion resulting in hyperinsulinism.
Strautz (1970) and Batchelor et al. (1975) supported the
possibility of the importance of an intrinsic islet cell
defect by suggesting that abnormalities in other tissues,
perhaps adipose tissue, may also play an important role in
the development of the syndrome.

It would then be reasonable

to look for a defect in glucose utilization by adipose

14

tissue.

Jefective glucose uptake and utilization, however,

have been observed

in vitro in ob/ob mouse muscle in the

absence of insulin ;Cuendet et al. 1976).

ihese results

suggested that the effects of insulin on the target tissue
may not be the primary cause of the disease.

If the insulin

effects are a conseluence and not a cause of the syndrome,
the tissues which exhibit glucose utilization and uptake
independent of insulin (e.g., erythrocytes and lens of the
eye) may also show abnormalities in those processes.
rhe purpose of this study was to determine the rate of
non-insulin stimulated glucose ut!,lization by islets of
Langerhans, epididymal fat segments, and erythrocytes.
Pancreatic islets were chosen because of their importance
in the development of the obese syndrome.

Adipose tissue was

selected because it is a major insulin target tissue and fat
deposition is the most visible characteristic of the syndrome.
Erythrocytes were chosen because their rate of glucose
transport and metabolism is not regulated by insulin.

Also,

fed corpuscles do not carry out respiration, glucose being
metabolized via glycolysis and the pentose phosphate pathway.
Deficient glucose utilization in erythrocytes would more
specifically indicate the location of that defect than would
deficient utilization of glucose in tissues with more
complex metabolism.

A defect in glucose utilization should,

since glucose metabolism in erythrocytes is limited to
glycolysis and the pentose phosphate shunt, indicate a
problem in some step in those pathways.

Deficient glucose

5
uptake could also be eliminated as a

cause of ,1 decreased

rate of metabolism since free glucose is found in red blood
cells.

7
the evolved tritiated water to the outer vial.

The vial

was removed from the water bath and allowed to cool to room
temperature.

rhe rubber stopper and inner vial were removed.

10 ml toluene-trition scintillation fluid was added to the
glass vial, and the radioactivity of the evolved water was
determined.

The counts per minute (CPM) obtained

were

corrected by subtracting from the vial CPM the CPM from a
vial with no tissue.

The corrected CPM of each vial were

divided by the total CPM in the original medium.

This

proportional fraction was then multiplied by the micrograms
of glucose in the original sample to obtain the amount of
glucose used by that tissue. This procedure measured glucose
utilization by assessing the total flux down the glycolytic
and pentose phosphate pathways (Larkins et al. 1980). It is
based on the fact that in the triose phosphate isomerase
reaction, or the enolase reaction, the

3H of the (5-3H)

glucose is lost to water (Ashcroft et al. 1970).

The

amount of water evolved was determined by liquid scintillation counting and the glucose used is calculated by relating
that fraction to the amount of glucose in the original
medium (Larkins et al. 1980.
Blood was obtained from the abdominal aorta and
collected in lightly heparinized tubes.

The tubes were

flame-sealed and spun five minutes in a hematocrit
centrifuge.

me packed erythrocytes were removed from the

capillary tubes with a ?2 gauge needle and glass syringe
rinsed with normal saline.

2he erythrocytes were washed

8
three times in 0.85% saline (pH 7.4).

rhe supernatant was

drawn off after the last washing,and lOul of packed
erythrocytes were placed in lOul of KRB solution in the inner
vial of the apparatus previously described for incubation.
Glucose utilized

WRS

recorded as micromoles of glucose

utilized per gram of hemoglobin per hour.
Pancreatic islets of Langerhans were isolated for
incubation bv using a variation of the technique described
by Lacy and Kostianovsky (1967).

The pancreas was removed

and trimmed of all fat, washed in Hank's solution, and cut
into pieces 2-4 mm in diameter.
placed in a

These pieces were then

lass conical centrifuge tube and washed in

several changes of Hank's solution until no fat was observed
in the solution.

The supernatant was drawn off with a

Pasteur pipette.

Two milligrams of type V collag,enase

(Sigma) were added to the tube to digest the exocrine matrix
and free the islets.

The tube was then capped and shaken

rapidly by hand in a water bath at 37 C until the endpoint was
reached.

The endpoint could be identified by close observa-

tion of the liquified mixture: within two minutes after
addition of the enzyme, the pancreatic tissue began to form
a sheet along the side of the tube.

Small breaks began to

appear in the sheet after 5-8 minutes of incubation.
matic digestion was stopped

Enzy-

t this point by the addition of

5 ml of ice-cold Hank's solution.

This mixture was spun at

low speed on a bench centrifuge for two minutes and the
supernatant decanted.

This procedure was repeated a total of

MATERIAL -3 AND METHODS

Animals used in this experiment were male C57b1/6J ob/ob
mice and their lean siblings, aged 52 weeks, which were
obtained from Temple University,

Moe were fed laboratory

rat chow a.1 libitum until they were sacrificed.

Mice were

first paralysed by severing the spinal cord so fresh blood
specimens could be obtained.

The animals were then killed

and tissues incubated as described below.
The procedure employed for incubation of tissues was
tnat described by Ashcroft et al. (1972), Larkins et al.
(1980), and Goodman and Coiro (1981).

A 2 ml plastic vial

(Technicon) was placed in a 20 ml glass scintillation vial.
The inner vial contained approximately 1 microcurie of
D-(5-3H) glucose (New England Nuclear) and Krebs-Ringer
bicarbonate medium (pH 7.4) at a volume of lOul with the
erythrocytes or 50u1 with adipose tissue or pancreatic
islets.

The KRB medium contained

3.5 mg/ii bovine albumin

and either 50, 100 or 200 mg/d1 glucose.

After addition of

the erythrocytes, islets, or fat segments to the inner vial,
the outer vial was sealed with a rubber stopper.

The

apparatus was incubated for one hour in a shaking water bath
at 100 strokes per minute at a temperature of

37 C.

Metabolism was stopped after one hour by the injection of
5u1 of 0.4 N HCI t

the inner vial via a needle inserted

through the rubber stopper.

The apparatus was incubated an

additional 20 hours to allow evaporation and condensation of

6

five times.

The last wash was carried out in Krebs-Ringer

bicarbonate medium with a glucose concentration of either
50, 100, or 200 mg/di.

The islets and medium were poured

into a flat gla ,3s dish, placed on a dark background, and
were examined under a dissecting microscope.

Free islets

were removed with a capillary tube and transferred to the
inner vial of the incubation apparatus.

Seven islets in

50u1 of KRB medium were incubated in each vial according
to the procedure described above.

Glucose utilization was

reported as picomoles of glucose per islet per hour.
Adipose tissue was taken from the epididymal fat pad.
Samples weighing- 0.012-0.018 g were taken from the distal
portion of the fat pad and washed in normal saline.

Each

segment was incubated in 50u1 KRB medium ,hith a glucose
concentration of either 50, 100. or 200 mg/di.

Results

were reported as micromoles of glucose utilized per gram
of tissue per hour.
Statistical analyses of the results obtained from each
of the tissues were made using the Student t-test.

RESULTS
Erythrocyte studies were carried out at 100 and 200
mg/al glucose, and significantly different results were
obtained at both concentrations (Figure 1).
utiliztion by the ob/ob cells

WRS

The glucose

significantly lower at

both levels than the rate of the control cells (Table 1).
At 100 mg/di glucose concentration, the mean rate of
utilization by the control erythrocytes was _.35uM glucose/
gram hemoglobin/hour, while that of the obere mice was
3.59uM glucose/gram hemoglobin/hour (Table 1; Figure 1).
At 200 mg/dl glucose, the control rate was 11.02uM
glucose/gram hemoglobin/hour.

The ob/ob erythrocyte rate

was 8.21uM/gram hemoglobin/hour (Table

Figure 1).

Comparisons made between the control and ob/ob cells with
the Student t-test showed significance at the 0.01 level.
Determinations carried out with adipose tissue also showed
a significant difference between control and ob/ob tissues
(Table 2).

Glucose utilization in adipose tissue taken from

obese and from control animals was determined at all three
concentrations' 50, 100, and 200 mg/al.

At 50 mg/al, the

mean rate of glucose utilization for control tissues

WRS

2.60uM glucose/gram tissue/hour and 0.99uM for ob/ob
tissue (Table 2; Figure 2). The control rate was 3.74uM
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TABLE 1
GLUCOSE UTILIZATION BY ERYTHROCYTES

Glucose
conc.
(mg/d1)

No. of
Replicates

Glucose
Utilized
(uM/g hgb/h)

S•d•

5

3.49

3.17

level
of
signif.

lOc
ob/ob
control

0.05

5.35

0.81

Z12
ob/Ob

4

8.21

0.54

control

5

11.02

0.46

0.05

11
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TABLE 2
GLUCOSE UTILIZATION BY EPIDIDYMAL FAT

Glucose

con c.
(mgAi1)

No. of
Replicates

Glucose
Utilized

(uM/g fat/h)

s.d.

level
of
signif.

.5.2
ob/ob

7

0.99

0.14

control

5

2.60

0.68

ob/Ob

8

1.69

0.28

control

6

3.74

0.62

ob/bb

5

1.5?

0.41

control

5

3.64

0.83

0.05

1Q2
0.05

2.9.1
0.05

t• •

Fig. 2
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glucose/gram tissue/hour nt 100 mg/d1 concentration, while
the ob/ob rate was 1.69uM (Table 2; ?igure 2).

At 200 mg/al,

the rate increased in the control tissue, but not in the
ob/ob tissue.

The mean control rate was 3.94uM glucose/gram

tissue/hour, whereas the ob/ob rate dropped slightly to
1.57uM (Table 2; Figure 2).

At each concentration the mean

rate of glucose utilization by obese and control mice
tissues differed at a highly significant level (Table 2).
This was demonstrated by the Student t-test in which the
level of significance was at 0.01.
Results of the ob/ob pancreatic tissue incubations were
highly erratic.

The ob/ob pancreatic islet utilization mean

was 69pM glucose/islet/hour at 100 mg/d1.
deviation was 19.

The standard

The control tissue utilization rate was

55.5pM glucose/islet/hour.

The standard deviation was 4.9

The ob/ob islets exhibited a utilization rate of 85.1pM
glucose/islet/hour at 200 medl glucose concentration.
standard deviation was 29.

The control rate of glucose

utilization at 200 mg/di wPr, 138pM/i3let/hour.
deviation was 15.

The

The standard

Because of the erratic nature of the ob/ob

islet incubation results, they were not included in the
graphic presentation.

DISCUSSION
The defective glucose utilization demonstrated in
erythrocytes was further evidence that the primary defect
in the obese mouse was not a localized one.

The presence

of defective glycolysis in erythrocytes also indicated
that the problem was not strictly insulin related.

Hyper-

insulinism or insulin resistance may have been implicated
previously as the primary defect in the syndrome because
of the effect of that hormone on the large tissue masses
of the animal

muscle and adipose.

The significance of a decreased rate of glucose
utilization in adipose tissue of the obese mouse was
emphasized by the conditions of the incubations.

Washed

objob epididymal fat segments, in the absence of insulin
or any exogenous hormone, demonstrated a slower rate of
glucose metabolism.

This observation reinforced the idea

that the condition was not caused by external factors, but
more likely as a result of a defect in the adipose tissue.
The difference in rates of utilization persisted in the
various glucose concentrations, ranging from that which
would correspond to an abnormally low blood sugar level to
a normal, high value (Lavin et al. 19771 7
,arthwaite et al.
1980).

That the adipose tissue defect was not entirely

16

17
the result of an insulin effect was supported by Abraham and
Beloff-Chain (1971).

They showed that a restricted diet

improved the hypergly^.emia and insulin resistant conditions,
but did not reduce the hyperinsulinism or obesity, indicating
that the insulin resistance was not the original problem in
the adipose tissue.
The erratic results obtained by incubation of islets
from ob(ob mice could not be used for any useful calculations,
but some information may be provided by these findings.

The

islets of the obese mice were observed to be larger than the
control islets.

Other authors have also reported ob/Ob

islets to be larger and more fragile than normal islets
(Findlay et al. 1973; Lavine et al. 1977).

The erratic

results obtained might nave resulted from the larger and
more fragile ob/Ob islets disrupting during incubation.
While the results of the incubation of the fat segments
suggested an intracellular defect, the evidence gleaned from
the erythrocyte studies was more indicative of a primary
problem.

It has been shown that glucose transport and

metabolism in erythrocytes are not regulated by insulin and
that that glucose metabolism is not dependent upon the rate
of glucose transport

Elbrink and Bihler, 1975).

Also, in

erythrocytes glucose is metabolized only by glycolysis and
the pentose phosphate pathway, the former accounting for
about ninety percent of the cells' metabolism.
used were washed several times and
medium.

rhecceatenne

The cells

laced in a hormone-free

of defective glucose metabolism in

18
erythrocytes under these conditions provided supporting
evidence that hyperinsulinism, insulin resistance, or hyperglycemia were not the primary cause of the syndrome.

The

report of Cuendet et al. (1976), which stated that In ijara
skeletal muscle exhibited defective glucose uptake and
metabolism, supported the idea of a generalized cellular
defect.

The authors also suggested that the same defect

may occur in the ventromedial hypothalamus, resulting in a
tendency to hyperphagia, which would lead to hyperglycemia,
ultimately causing hyperinsulinism.

The hyperinsulinism

would result in insulin resistance and compound a problem
already existing in the muscle tissue.

Bereiter and

Jeanrenaud (1979) and Van der Kroan and Speijers (1979)
reported anatomical deficiencies in the VMH of the cb/Ob
mouse which reinforces this theory.
supported by Baile et al. (1970).

This idea was also
The possibility of a

hypothalmic lesion being the primary defect has been given
little support.

According to Stauffacher and Renold (1969)

and Kasuga et al. (1980), a VMH lesion was not solely
responsible for the syndrome.

They showed that mice with a

VMH lesion did not exhibit the severity of symptoms seen in
the ob/ob mouse, indicating that there was another factor at
work in the development of the syndrome.
supported the idea of a localized defect.

The results again
?urther investi-

gations of the glucose utilization in individual tissues,
especially those not sensitive to insulin, are needed to
help determine the significance of the evidence supporting

19
this possibility.
The ob/ob mouse is consijered an important experimental
model for non-insulin dependent diabetes (Carnie and Smith
19801 Carthwaite et al. 1980).

The importance, therefore,

of increased understanding of this mutation is not only
valuable for the study of inborn errors of metabolism in the
experimental animal, but in the possible application of tnat
knowledge to a better understanding of some forms of noninsulin dependent diabetes in humans as well.
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